Filing Flows

Filing Flows › Syndax Pharmaceuticals (SNDX) › Who owns the stock

Who owns Syndax Pharmaceuticals (SNDX) stock

233 funds reported Syndax Pharmaceuticals (SNDX) shares in their latest 13F filings, worth $2.5B in all. The largest holder is BlackRock ($197M). Last quarter 124 funds added to their stakes and 105 cut them.

Largest holders of SNDX (13F)Largest holders of SNDX (13F)BlackRock$197MKynam Capital Management, LP$176MVanguard Group$131MGoldman Sachs Group$128MState Street$124MBank of America$88.4MVanguard Capital Management LLC$85.9MDeerfield Management Company, L.P…$82.6MEversept Partners, LP$61.2MGeode Capital Management, LLC$56.5M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock9,020,006$197Mincrease2026-06-30
Kynam Capital Management, LP8,050,959$176Munchanged2026-06-30
Vanguard Group6,230,334$131Mincrease2025-12-31
Goldman Sachs Group5,861,265$128Mincrease2026-06-30
State Street5,658,424$124Mincrease2026-06-30
Bank of America4,045,094$88.4Mdecrease2026-06-30
Vanguard Capital Management LLC3,927,892$85.9Mincrease2026-06-30
Deerfield Management Company, L.P. (series C)3,779,900$82.6Munchanged2026-06-30
Eversept Partners, LP2,798,210$61.2Mdecrease2026-06-30
Geode Capital Management, LLC2,584,136$56.5Mincrease2026-06-30
Hood River Capital Management LLC2,564,279$56.1Mincrease2026-06-30
Kingdon Capital Management, L.L.C.2,500,000$54.6Munchanged2026-06-30
Franklin Resources2,286,499$50.0Mincrease2026-06-30
Millennium Management LLC2,053,960$44.9Mincrease2026-06-30
Vanguard Portfolio Management LLC1,921,796$42.0Mincrease2026-06-30

Syndax Pharmaceuticals' latest quarter

Syndax Pharmaceuticals, Q3 2026: revenue $83.3M (+82% year over year), operating margin -50.3%, net loss $49.4M, operating cash flow −$27.3M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most SNDX stock?

By the latest 13F filings: BlackRock ($197M); Kynam Capital Management, LP ($176M); Vanguard Group ($131M); Goldman Sachs Group ($128M); State Street ($124M).

What is the short interest in SNDX?

18,001,644 shares were sold short at the 2026-10-15 settlement, -1.28% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.